Freestone Grove Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,501
Closed -$132K 773
2024
Q4
$132K Buy
+12,501
New +$132K ﹤0.01% 552